Jambusar Bulk Drug Park: Gujarat Approves Incentives as GIDC Takes Applications Until 25 November

Gujarat has approved a special incentive scheme for units that set up in the upcoming bulk drug park at Jambusar in Bharuch district. Separately, the Gujarat Industrial Development Corporation (GIDC) has advertised online applications for the park from 26 October to 25 November 2026.

If you make active pharmaceutical ingredients (APIs), key starting materials (KSMs) or drug intermediates, that closing date is the part to act on. The incentives look substantial on paper, but the reports give only the headline terms, not the figures you would need for a project budget. Here is what is known and what is not.

What the dedicated scheme offers

The Times of India and IANS, both reporting the state government's announcement, list these incentives under the dedicated Bulk Drug Park Scheme:

• 10% capital subsidy on eligible fixed capital investment.
• Reimbursement of utility charges for up to 10 years, covering power, steam, water, effluent treatment, solid waste management, warehousing and park maintenance.
• 100% reimbursement of stamp duty and registration fees on the first allotment of land in the park.
• Special interest subsidies for eligible micro, small and medium enterprises (MSMEs).

Two words in that list carry a lot of weight: "eligible" and "up to". The reports do not define what counts as eligible investment or who counts as an eligible MSME. Nor do they say how much of each utility bill would be reimbursed, or whether the amount changes over the period.

Two routes, and you pick one

Investors can choose between the dedicated Bulk Drug Park Scheme and the Viksit Gujarat Industrial Policy 2026, depending on their project requirements. Maritime Gateway describes the two as alternatives, and IANS says investors may choose the policy instead. So plan on one route, not on combining them.

The reports do not compare the two for a unit in this park. To make that choice, you will need the text of both, not a news summary of one.

The GIDC application window

GIDC's advertisement invites online applications for the bulk drug park at Jambusar, Bharuch, from 26 October to 25 November 2026. Applications go online through GIDC, and its website carries a link to apply.

The advertisement page itself does not give plot sizes, pricing or allotment conditions. We have not seen a published description of the allotment process, so we are not describing any steps beyond this.

What the park is meant to be

The project is spread across around 2,015 acres and, according to Health Xplore, is being developed by GIDC. The Times of India describes it as a plug-and-play industrial ecosystem, with shared infrastructure intended to reduce the capital and operating costs of pharmaceutical manufacturers.

The park will have more than 10 common infrastructure facilities. Those named in the report include:

• A common effluent treatment plant.
• Steam generation and distribution networks.
• Solvent recovery facilities.
• Facilities for treating and disposing of hazardous waste.
• Deep-sea disposal infrastructure.
• A centre of excellence.
• Multi-modal logistics connectivity.

The stated aim is to encourage domestic production of APIs, KSMs and drug intermediates, and to reduce reliance on overseas suppliers. The state government also expects the project to attract substantial investment and create jobs for thousands of skilled and semi-skilled workers. Those are the government's expectations, not results.

On timing, only one outlet gives a date

Health Xplore reports that completion is expected by March 2027. The other reports we reviewed give no commissioning timeline, so treat that date as one outlet's report and not as a confirmed commitment. The reports also do not say whether plots can be allotted before the common infrastructure is finished.

This matters if your plan depends on the shared effluent or steam facilities being ready when your unit is.

What the reports do not tell you

These details are not in the reports we reviewed, and we will not guess at them:

• Plot prices and plot sizes.
• Detailed eligibility for the scheme or for the allotment.
• Caps on the 10% capital subsidy or on other incentives.
• MSME interest-subsidy amounts or limits.
• The allotment process, including how applications will be assessed.

GIDC's allotment documents are the place to look for these. Read them before you commit money or board time to this.

What this means for you

If you are a pharma MSME or an API, KSM or intermediate maker, a sensible approach to the next few weeks is:

• Treat 25 November 2026 as your working deadline. Decide early whether this site fits your plans, so the closing date does not make the decision for you.
• Read GIDC's allotment documents first. Plot price, plot size and allotment conditions will shape your project cost more directly than the headline subsidy.
• Cost the project under both routes. Run your numbers under the dedicated scheme and under the Viksit Gujarat Industrial Policy 2026, using the official text for each.
• Keep incentives out of your base case for now. Until caps and eligibility are clear, do not count the capital subsidy or the utility reimbursement as money you can rely on. Show your lender or investors the plan without them, then with them as an upside.
• Do not assume you qualify for the MSME benefit. The interest subsidies are for eligible MSMEs, and neither the test nor the amount has been reported. Look for both in the official documents.
• Plan around your own dependency on shared facilities. If you need the common effluent plant or steam supply from your first day of production, look for a firm readiness date in the official documents before you commit to a schedule.

The park may suit a maker who wants shared infrastructure and is ready to move now. Whether the economics work depends on figures that are not yet in the reports.

Sources: The Times of India and IANS via Punjab Kesari on the state government's incentive announcement; the Gujarat Industrial Development Corporation advertisement on the application window; Maritime Gateway on the choice between the two routes; Health Xplore on the developer, target users and expected completion.

Cover photo: Julia Koblitz on Unsplash